Results 271 to 280 of about 4,287,179 (359)

In silico structural and docking models of dipteran FXPRLamide neuropeptides support ligand-receptor coevolution and suggest mechanisms for ligand bias. [PDF]

PLoS One
Farris SM.
europepmc   +1 more source

pH-dependent structural dynamics of neuropeptide Y in aqueous solution. [PDF]

PLoS One
Nguyen HT, Spehr M, Bondar AN, Carloni P.   +3 more
europepmc   +1 more source

Reproductive and sexual sequelae of neuroendocrine tumour therapies: an under-recognised challenge. [PDF]

Endocr Relat Cancer
Shekhda KM, Shah PM, Biddanda A, Grossman A, Caplin M.   +4 more
europepmc   +1 more source

Peptide Drugs in Gastrointestinal Tumors: Integrating Targeting, Delivery, and Therapeutic Actions for Synergistic Strategies. [PDF]

Biomolecules
Ouyang Q, Wu G, Chen A, Zhang R, Xiao S, Guo D, Zhang Q, Yan C, Chen XZ, Tang J, Lyu H.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Formyl-peptide receptors revisited

Trends in Immunology, 2002
Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors. The first chemotactic factors to be structurally defined were the N-formyl peptides. Unlike other leukocyte chemoattractants, N-formyl peptides could originate from
Yingying, Le, Philip M, Murphy, Ji Ming, Wang   +2 more
openaire   +3 more sources

Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

Endocrine Reviews, 2003
Jean Claude Reubi
exaly   +2 more sources